Scholars Central

Case reportPublished 16 Nov 2022

Novel antiviral and anitbacterial drugs and novel drug supplement interactions

Authors: John Shelby

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Novel Covid previously showed up in Wuhan, China, in December 2019, and it rapidly extended all around the world. A few meds which are utilized to treat different illnesses appear to be compelling in treating Coronavirus even without express help. The current medications that are summed up in this audit fundamentally centered on remedial specialists that had action against other RNA infections like MERS-CoV and SARS-CoV. Drug reusing or repositioning is a promising field in drug disclosure that distinguishes new helpful open doors for existing medications like corticosteroids, RNA-subordinate RNA polymerase inhibitors, interferons, protease inhibitors, ivermectin, melatonin, teicoplanin, and some others.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases and Medical Microbiology
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “John Shelby”